Sponsored Content
New Symrise CEO Parisot looks optimistic into 2024 at the Annual General Meeting
– Dr. Jean-Yves Parisot welcomes shareholders to the townhall Holzminden for the first time in his new role
– CEO presents stable financial figures for past financial year
– Holzminden-based Group closes first quarter of 2024 with very good sales growth
Symrise held its Annual General Meeting on May 15, 2024. For the first time this took place with the new CEO. In his speech, Dr. Jean-Yves Parisot welcomed the nearly 350 shareholders gathered in the townhall of Holzminden for the first time in his new role. He also thanked his predecessor Dr. Heinz-Jürgen Bertram for his many years of service. His following presentation featured an overview of the development and strategy of the Holzminden-based Group.
“I feel delighted to speak at the Symrise Annual General Meeting for the first time as the Group’s CEO,” said Dr. Jean-Yves Parisot. “We offer our shareholders good opportunities for successful business development, also amid ongoing global uncertainties. Our diversified portfolio, our high level of innovation and our global positioning contribute significantly to this. Our pioneering role in sustainability represents a further key to our success. We want to continue intensifying our efforts in this area until we have achieved net-zero status at all levels by 2045.”
In his presentation to the nearly 350 shareholders present, the new CEO started with a look at the 2023 fiscal year. The year turned out a successful one also with its geopolitical uncertainties. It produced stable organic sales growth of just under eight percent. Both divisions (Taste, Nutrition & Health as well as Scent & Care) recorded significant growth.
In his outlook for the 2024 fiscal year, Parisot stated that Symrise feels confident that it will be able to continue along this successful course. In the first quarter of 2024, the Group managed to increase sales by just under 11% compared with the first quarter of 2023. Overall, Symrise is aiming for organic growth of between five and seven percent this year. This would place the company at a faster growth rate than its respective market. To increase profitability, the company has also launched an efficiency program worth EUR 50 million.

Voting results available online
After the presentation of the business figures, the agenda continued to cover the agenda items up for vote. They included the following topics:
23 Feb 2026
PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.
Read more
12 Feb 2026
Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.
Read more
22 Jan 2026
The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.
Read more
6 Jan 2026
HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...
Read more
22 Dec 2025
PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...
Read more
11 Dec 2025
Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...
Read more
11 Dec 2025
Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...
Read more
11 Dec 2025
Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...
Read more
4 Dec 2025
Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.
Read more
1 Dec 2025
Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market
Read more